Stem Cell Stocks 3/28/09: The Week That Was

This was a nice bounce back week for the stem cell stocks. For a quite a bit of time, it appeared that the market had forgotten this entire sector, but things finally seemed to take a turn for the better. Nothing really earth shattering happened to cause the change in sentiment. As result, I can only conclude that it was the stem cell stocks' turn to catch up.

I recently decided to make a modification to this blog. Because many of the stem cell stocks have technically detached from the previous pivot point of 1/23/09, I've decided to now track each stock based on their weekly performance.

Top Stem Cell Stock Performer(s) for Last Week:

- Advanced Cell Technology (ACTC.OB) = Up 67% for the week; If you remember, ACTC.OB was the worst performer last week. This week there was no major news, but as I figured, it bounced right back.

Worst Stem Cell Stock Performer(s) for Last Week:

- Osiris Therapeutics (OSIR) = Down -21% for the week; This tanked due to the company discontinuing a phase III Crohn's Disease trial.

- Stem Cell Innovations (SCLL.PK) = Down -20% for the week; Another one of those stocks significantly beaten in the stem cell sector the past 3 weeks on no news. It seems to be following a similar trend as ACTC.OB. I eventually think this trend should reverse.

Stem Cell Stocks Current Price and % Up or Down 3/23/09 - 3/27/09

Market Cap Over 50 Million

Ariad Pharmaceuticals (ARIA) = Current Price: $1.36; Up 9%
Aastrom Biosciences (ASTM) = Current Price: $0.40; Up 14%
BioTime, Inc. (BTIM) = Current Price: $2.10; Up 2%
Celgene Corp (CELG) = Current Price: $46.04; Up 1%
Cytori Therapeutics (CYTX) = Current Price: $1.80; Up 5%
Geron Corp (GERN) = Current Price: $4.89; Up 20%
ThermoGenesis (KOOL) = Current Price: $0.60; Up 18%
Osiris Therapeutics (OSIR) = Current Price: $14.32; Down -21%
StemCell Inc. (STEM) = Current Price: $1.81; Up 21%

Market Cap Under 50 Million

Advanced Cell Technology (ACTC.OB) = Current Price: $0.125; Up 67%
Athersys Inc. (ATHX) = Current Price: $0.87; Up 10%
Brainstorm Cell Therapeutics (BCLI.OB) = Current Price: $0.09; Unchanged
Bioheart Inc. (BHRT) = Current Price: Current Price: $0.60; Up 2%
Cord Blood America Inc. (CBAI.OB) = Current Price: $0.0086; Up 23%
Cyro-Cell Intl (CCEL.OB) = Current Price: $0.62; Up 7%
Neuralstem (CUR) = Current Price: $1.06; Up 6%
International Stem Cell (ISCO.OB) = CurrentPrice: $0.50; Up 6%

LifeStem International (LSTM.OB) = Current Price: $0.0075; Up 15%
MultiCell Technologies (MCET.OB) = Current Price: $0.0135; Unchanged
Pluristem Therapeutics (PSTI) = Current Price: $1.35; Up 16%
Stem Cell Therapy Intl (SCII.OB) = Current Price: $0.08; Unchanged
Stem Cell Innovations (SCLL.PK) = Current Price: $0.006; Down -20%

Possible Catalyst(s) for the Week:

- Again, be on the lookout for further legislative movement to support President Obama's executive order.

- More Mutual fund distribution of funds originally allocated for Genentech. It will take quite a while to redistribute these dollars throughout the biotech sector.

- M&A (mergers and acquisitions) activity will be key. It could happen at any time.

Ending Thoughts:

My gut feeling tells me that the market will trade higher on Monday, but will slide lower the rest of the week. The quarter is coming to an end and after such thunderous gains, the market may be looking to take a breather. If this does take place, DOW 8000 becomes the new technical point of resistance. It's hard to determine where exactly this leaves the stem cell stocks, but be mindful that a pullback may occur.

1 comment:

  1. Here's a site that ferrets out the stocks in those teaser emails that we're constantly besieged with. You can sign up for the free email service and let the Stock Gumshoe smoke out the stocks without taking out the subscriptions. Very well written.

    So … no great wisdom here from the Gumshoe, but at least I can tell you that these appear to be the first two companies teased by Hot Stock Confidential as their “Three Biotechs that Could Revolutionize Medicine (and make you RICH!)
    Whether they’ll do so or not is, of course, quite an open question. I can’t tell you whether their drugs will work, or whether the shares will really climb by 422% … but I can listen, so if you’ve got an opinion or more information on these, feel free to share with a comment below.

    And “Company C” is related to stem cells … more on that later in the week (see? The Gumshoe can “tease” too!).